SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-153598
Filing Date
2022-05-18
Accepted
2022-05-18 08:00:32
Documents
12
Period of Report
2022-05-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d252044d8k.htm   iXBRL 8-K 23353
  Complete submission text file 0001193125-22-153598.txt   140673

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zsan-20220516.xsd EX-101.SCH 2872
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20220516_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20220516_pre.xml EX-101.PRE 10823
6 EXTRACTED XBRL INSTANCE DOCUMENT d252044d8k_htm.xml XML 3264
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36570 | Film No.: 22937103
SIC: 2834 Pharmaceutical Preparations